Regulation of host and viral promoters during human cytomegalovirus latency via US28 and CTCF.


Journal

The Journal of general virology
ISSN: 1465-2099
Titre abrégé: J Gen Virol
Pays: England
ID NLM: 0077340

Informations de publication

Date de publication:
05 2021
Historique:
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 12 8 2021
Statut: ppublish

Résumé

Viral latency is an active process during which the host cell environment is optimized for latent carriage and reactivation. This requires control of both viral and host gene promoters and enhancers often at the level of chromatin, and several viruses co-opt the chromatin organiser CTCF to control gene expression during latency. While CTCF has a role in the latencies of alpha- and gamma-herpesviruses, it was not known whether CTCF played a role in the latency of the beta-herpesvirus human cytomegalovirus (HCMV). Here, we show that HCMV latency is associated with increased CTCF expression and CTCF binding to the viral major lytic promoter, the major immediate early promoter (MIEP). This increase in CTCF binding is dependent on the virally encoded G protein coupled receptor, US28, and contributes to suppression of MIEP-driven transcription, a hallmark of latency. Furthermore, we show that latency-associated upregulation of CTCF represses expression of the neutrophil chemoattractants S100A8 and S100A9 which we have previously shown are downregulated during HCMV latency. As with downregulation of the MIEP, CTCF binding to the enhancer region of S100A8/A9 drives their suppression, again in a US28-dependent manner. Taken together, we identify CTCF upregulation as an important mechanism for optimizing latent carriage of HCMV at both the levels of viral and cellular gene expression.

Identifiants

pubmed: 34042564
doi: 10.1099/jgv.0.001609
pmc: PMC8295918
doi:

Substances chimiques

CCCTC-Binding Factor 0
CTCF protein, human 0
Calgranulin A 0
Calgranulin B 0
Receptors, Chemokine 0
S100A8 protein, human 0
S100A9 protein, human 0
US28 receptor, Cytomegalovirus 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 109075/Z/15/A
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0701279
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S00081X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K021087/1
Pays : United Kingdom

Références

J Clin Virol. 2008 Mar;41(3):180-5
pubmed: 18164651
PLoS One. 2009 Jul 01;4(7):e6109
pubmed: 19568426
PLoS Pathog. 2011 Aug;7(8):e1002140
pubmed: 21876668
J Virol. 2016 Sep 29;90(20):9483-94
pubmed: 27512069
J Virol. 2020 Jan 6;94(2):
pubmed: 31666380
J Virol. 2010 Jun;84(11):5594-604
pubmed: 20335255
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11137-42
pubmed: 8855322
Cell Rep. 2018 Jul 17;24(3):594-606
pubmed: 30021158
Endocrinology. 2003 Oct;144(10):4420-6
pubmed: 12960026
J Virol. 2017 Feb 14;91(5):
pubmed: 27974567
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20039-44
pubmed: 21041645
J Biol Chem. 2017 Apr 21;292(16):6542-6554
pubmed: 28242760
Sci Adv. 2015 Nov 27;1(10):e1501164
pubmed: 26702450
J Virol. 2013 Apr;87(8):4261-71
pubmed: 23365437
J Virol. 2006 Mar;80(5):2358-68
pubmed: 16474142
Elife. 2015 Apr 07;4:
pubmed: 25846574
Cell. 2009 Jun 26;137(7):1194-211
pubmed: 19563753
J Gen Virol. 2012 Apr;93(Pt 4):722-732
pubmed: 22238232
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1755-1764
pubmed: 30647114
J Virol. 2004 Feb;78(3):1440-7
pubmed: 14722299
Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):286-95
pubmed: 19682613
BMC Bioinformatics. 2015 May 01;16:140
pubmed: 25927199
J Virol. 2009 Jun;83(11):5615-29
pubmed: 19297488
Nucleic Acids Res. 2013 Jan;41(Database issue):D188-94
pubmed: 23193294
mBio. 2019 Dec 3;10(6):
pubmed: 31796538
Blood. 2006 Dec 1;108(12):3691-9
pubmed: 16931631
Blood. 2002 Oct 15;100(8):2867-73
pubmed: 12351397
J Virol. 2019 Jun 14;93(13):
pubmed: 30996085
Cell Microbiol. 2021 Feb;23(2):e13274
pubmed: 33006186
PLoS Pathog. 2013;9(5):e1003366
pubmed: 23717203
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
mBio. 2018 Feb 6;9(1):
pubmed: 29437926
J Virol. 2018 Mar 28;92(8):
pubmed: 29437965
Exp Mol Med. 2015 Jun 05;47:e166
pubmed: 26045254
J Virol. 2013 Feb;87(3):1789-99
pubmed: 23192870
Nat Microbiol. 2018 Apr;3(4):503-513
pubmed: 29588542
Virology. 2010 Nov 25;407(2):171-7
pubmed: 20855098
Sci Rep. 2017 Apr 11;7(1):810
pubmed: 28400599
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3937-42
pubmed: 9520471
Elife. 2018 Jun 26;7:
pubmed: 29941091
mBio. 2017 Dec 5;8(6):
pubmed: 29208743
Semin Cancer Biol. 2014 Jun;26:22-9
pubmed: 24468737
J Virol. 2014 Jul;88(13):7389-401
pubmed: 24741094
Viruses. 2018 Aug 20;10(8):
pubmed: 30127279
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16255-60
pubmed: 12456880
Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):E10586-E10595
pubmed: 29158406
PLoS Biol. 2018 Oct 25;16(10):e2005752
pubmed: 30359362
J Virol. 2018 May 14;92(11):
pubmed: 29514910
mBio. 2018 Mar 13;9(2):
pubmed: 29535194
PLoS Pathog. 2016 May 24;12(5):e1005655
pubmed: 27218650
J Gen Virol. 1991 Sep;72 ( Pt 9):2059-64
pubmed: 1654370
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4140-5
pubmed: 15738399
Blood. 2009 Nov 5;114(19):4128-37
pubmed: 19706889
J Gen Virol. 1996 Dec;77 ( Pt 12):3099-102
pubmed: 9000102
Blood. 2007 Aug 1;110(3):937-45
pubmed: 17440050
iScience. 2019 Feb 22;12:13-26
pubmed: 30677738
J Virol. 2015 Dec 30;90(6):2959-70
pubmed: 26719258
Methods Mol Biol. 2014;1119:81-98
pubmed: 24639219
J Virol. 2014 Dec;88(24):13947-55
pubmed: 25253336
J Gen Virol. 2016 Sep;97(9):2387-2398
pubmed: 27411311
Med Microbiol Immunol. 2015 Jun;204(3):421-9
pubmed: 25772624
Med Microbiol Immunol. 2019 Aug;208(3-4):431-438
pubmed: 30761409
Viruses. 2015 Jul 06;7(7):3574-85
pubmed: 26154016

Auteurs

Elizabeth G Elder (EG)

Present address: Public Health Agency of Sweden, Solna, Sweden.
Department of Medicine, University of Cambridge, Cambridge, UK.

Benjamin A Krishna (BA)

Department of Medicine, University of Cambridge, Cambridge, UK.

Emma Poole (E)

Department of Medicine, University of Cambridge, Cambridge, UK.

Marianne Perera (M)

Department of Medicine, University of Cambridge, Cambridge, UK.

John Sinclair (J)

Department of Medicine, University of Cambridge, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH